4//SEC Filing
IDERA PHARMACEUTICALS, INC. 4
Accession 0001179110-17-008809
CIK 0000861838operating
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:15 PM ET
Size
5.7 KB
Accession
0001179110-17-008809
Insider Transaction Report
Form 4
REARDON WILLIAM S
Director
Transactions
- Award
Stock Options
2017-06-07+50,000→ 50,000 totalExercise: $1.63From: 2018-06-07Exp: 2027-06-07→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These options were granted pursuant to the Company's director compensation on the date of the Company's 2017 annual meeting of stockholders at an exercise price to the closing price of the Company's common stock on the date of grant.
- [F2]These options will vest in full and become immediately exercisable on the first anniversary of the date of grant, subject to continued service as director, and are granted under the Company's 2013 Stock Incentive Plan, as amended.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000861838
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:15 PM ET
- Size
- 5.7 KB